Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Community crystal gazing

An Erratum to this article was published on 09 June 2016

This article has been updated

A selection of individuals from the biotech ecosystem give their views on the challenges facing the sector over the coming years.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8: Profit/loss for public biotech sector over time.

Change history

  • 31 March 2016

    In the version of this article initially published, Stanley Crooke's name was misspelled as “Crook” in the author list. The error has been corrected in the HTML and PDF versions of the article.

Author information

Authors and Affiliations

Authors

Supplementary information

Supplementary Tables

Supplementary Tables 1–4 (PDF 186 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Acharya, A., Bingham, K., Bradner, J. et al. Community crystal gazing. Nat Biotechnol 34, 276–283 (2016). https://doi.org/10.1038/nbt.3515

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.3515

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research